NBDF’s Pathway to Cures Announces Spark Biomedical’s LUNA Trial to Advance Non-Pharmaceutical Options for Heavy Menstrual Bleeding
For women and girls with bleeding disorders, heavy menstrual bleeding (HMB) is one of the most debilitating—and ignored—symptoms they endure. According to data from the National Bleeding Disorder’s (NBDF) Community Voices in Research registry, 46% of women with a bleeding disorder reported missing school or work due to it. Now, a Phase II decentralized clinical study is enrolling participants to test a drug-free alternative: transcutaneous auricular neurostimulation, a wearable technology that stimulates the nervous system through the ear to reduce heavy menstrual bleeding.
76th Annual Bleeding Disorders Conference at Georgia World Congress Center
The National Bleeding Disorders Foundation (NBDF) is hosting its 76th Annual Bleeding Disorders Conference (BDC) from September 12-14, 2024, at the Georgia World Congress Center in Atlanta, GA.
The National Hemophilia Foundation is Now the National Bleeding Disorders Foundation
The National Hemophilia Foundation (NHF) has officially changed its name to the National Bleeding Disorders Foundation (NBDF). Foundation leaders announced the change alongside advocates and supporters at the 2023 Bleeding Disorders Conference in National Harbor, MD.
